LOCATION & DURATION
All internships will be based in our Shanghai office. This internship starts in June 2026 for approximately 10-12 weeks. This is a full-time (40 hours per week) paid internship.
POSITION SUMMARY
- Support company event, internal communication, admin tasks, and lab operations. Looking for student with good organizational and communication skills.
ESSENTIAL DUTIES AND RESPONSIBILITIES
- Support on planning, communication, and execution of company-wide events.
- Provide administrative support to the operations department including data entry, record keeping, and report generation.
- Assist with the coordination of lab operations including procurement to payment process of laboratory supplies, coordination of equipment management.
REQUIREMENTS
- Pursuing a Bachelor’s degree in Life Sciences or related fields.
- Good organizational skills with the ability to manage multiple tasks and prioritize accordingly.
- Strong attention to detail with a focus on accuracy and compliance.
- Good interpersonal and communication skills with the ability to collaborate with different departments and levels of management.
- Proficiency in Microsoft Excel, Word, and PowerPoint.
- A full-time student in an accredited program with plans to return to school in the fall
- All applicants must be at least 18 years of age by June 1, 2026.
Travel
- None
Skills Required
- Pursuing a Bachelor's degree in Life Sciences or related fields
- Ability to manage multiple tasks and prioritize
- Strong attention to detail with focus on accuracy
- Good interpersonal and communication skills
- Proficiency in Microsoft Excel, Word, and PowerPoint
- Full-time student with plans to return to school in the fall
- Must be at least 18 years of age by June 1, 2026
What We Do
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
